198 related articles for article (PubMed ID: 23935482)
1. A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.
Balzarini J; Andrei G; Balestra E; Huskens D; Vanpouille C; Introini A; Zicari S; Liekens S; Snoeck R; Holý A; Perno CF; Margolis L; Schols D
PLoS Pathog; 2013; 9(7):e1003456. PubMed ID: 23935482
[TBL] [Abstract][Full Text] [Related]
2. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
3. Conservation of antiviral activity and improved selectivity in PMEO-DAPym upon pyrimidine to triazine scaffold hopping.
de Castro S; Fernández-Cureses G; Andrei G; Snoeck R; Sánchez-Murcia PA; Korba B; Gago F; Balzarini J; Camarasa MJ
Antiviral Res; 2015 Oct; 122():64-8. PubMed ID: 26275802
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy.
Bestman-Smith J; Boivin G
J Med Virol; 2002 May; 67(1):88-91. PubMed ID: 11920821
[TBL] [Abstract][Full Text] [Related]
5. Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.
Balzarini J; Schols D; Van Laethem K; De Clercq E; Hocková D; Masojidkova M; Holý A
J Antimicrob Chemother; 2007 Jan; 59(1):80-6. PubMed ID: 17124193
[TBL] [Abstract][Full Text] [Related]
6. Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.
Andrei G; Lisco A; Vanpouille C; Introini A; Balestra E; van den Oord J; Cihlar T; Perno CF; Snoeck R; Margolis L; Balzarini J
Cell Host Microbe; 2011 Oct; 10(4):379-89. PubMed ID: 22018238
[TBL] [Abstract][Full Text] [Related]
7. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
8. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
9. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
[TBL] [Abstract][Full Text] [Related]
10. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2.
Sadowski LA; Upadhyay R; Greeley ZW; Margulies BJ
Viruses; 2021 Jun; 13(7):. PubMed ID: 34202050
[TBL] [Abstract][Full Text] [Related]
11. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
[TBL] [Abstract][Full Text] [Related]
12. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
[TBL] [Abstract][Full Text] [Related]
13. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
14. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
16. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
[TBL] [Abstract][Full Text] [Related]
18. The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization.
Herman BD; Votruba I; Holy A; Sluis-Cremer N; Balzarini J
J Biol Chem; 2010 Apr; 285(16):12101-8. PubMed ID: 20164190
[TBL] [Abstract][Full Text] [Related]
19. Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131.
Cihlar T; Ray AS; Boojamra CG; Zhang L; Hui H; Laflamme G; Vela JE; Grant D; Chen J; Myrick F; White KL; Gao Y; Lin KY; Douglas JL; Parkin NT; Carey A; Pakdaman R; Mackman RL
Antimicrob Agents Chemother; 2008 Feb; 52(2):655-65. PubMed ID: 18056282
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
